# Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

> **NCT00085488** · PHASE1 · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center**

## Conditions studied

- Melanoma (Skin)

## Interventions

- **BIOLOGICAL:** autologous tumor cell vaccine
- **BIOLOGICAL:** therapeutic autologous dendritic cells

## Key facts

- **NCT ID:** NCT00085488
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** — (—)
- **Last updated:** 2015-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00085488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00085488, "Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00085488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*